Literature DB >> 15028556

Autoantibodies and thrombophilia in RA: TNFalpha and TNFalpha blockers.

G F Ferraccioli1, E Gremese.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15028556      PMCID: PMC1755038          DOI: 10.1136/ard.2003.015586

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  41 in total

1.  In vivo neutralization of TNF-alpha promotes humoral autoimmunity by preventing the induction of CTL.

Authors:  C S Via; A Shustov; V Rus; T Lang; P Nguyen; F D Finkelman
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

2.  Bacterial induction of autoantibodies to beta2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome.

Authors:  Miri Blank; Ilan Krause; Mati Fridkin; Nathan Keller; Juri Kopolovic; Iris Goldberg; Ana Tobar; Yehuda Shoenfeld
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

3.  The prevalence and clinical associations of anticardiolipin antibodies in a large inception cohort of patients with connective tissue diseases.

Authors:  P A Merkel; Y Chang; S S Pierangeli; K Convery; E N Harris; R P Polisson
Journal:  Am J Med       Date:  1996-12       Impact factor: 4.965

4.  Anticardiolipin antibodies in rheumatoid patients treated with etanercept or conventional combination therapy: direct and indirect evidence for a possible association with infections.

Authors:  G Ferraccioli; F Mecchia; E Di Poi; M Fabris
Journal:  Ann Rheum Dis       Date:  2002-04       Impact factor: 19.103

5.  Lectin-like oxidized LDL receptor-1 is a cell-adhesion molecule involved in endotoxin-induced inflammation.

Authors:  Megumi Honjo; Kayo Nakamura; Kenji Yamashiro; Junichi Kiryu; Hidenobu Tanihara; Leslie M McEvoy; Yoshihito Honda; Eugene C Butcher; Tomoh Masaki; Tatsuya Sawamura
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

6.  C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

Authors:  Sridevi Devaraj; Dan Yan Xu; Ishwarlal Jialal
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

Review 7.  Inflammation in atherosclerosis.

Authors:  Peter Libby
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study.

Authors:  Gunnar Engström; Lars Stavenow; Bo Hedblad; Peter Lind; Karl-Fredrik Eriksson; Lars Janzon; Folke Lindgärde
Journal:  Diabetes       Date:  2003-02       Impact factor: 9.461

9.  Rescue of combination therapy failures using infliximab, while maintaining the combination or monotherapy with methotrexate: results of an open trial.

Authors:  G F Ferraccioli; R Assaloni; E Di Poi; E Gremese; G De Marchi; M Fabris
Journal:  Rheumatology (Oxford)       Date:  2002-10       Impact factor: 7.580

10.  Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.

Authors:  David Hürlimann; Adrian Forster; Georg Noll; Frank Enseleit; Rémy Chenevard; Oliver Distler; Markus Béchir; Lukas E Spieker; Michel Neidhart; Beat A Michel; Renate E Gay; Thomas F Lüscher; Steffen Gay; Frank Ruschitzka
Journal:  Circulation       Date:  2002-10-22       Impact factor: 29.690

View more
  1 in total

1.  TNF-alpha blockade induces a reversible but transient effect on endothelial dysfunction in patients with long-standing severe rheumatoid arthritis.

Authors:  Silvia Bosello; Angelo Santoliquido; Angelo Zoli; Cristiana Di Campli; Roberto Flore; Paolo Tondi; GianFranco Ferraccioli
Journal:  Clin Rheumatol       Date:  2007-12-13       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.